The Queen's Drive, United Kingdom

Monika Bokori-brown


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Monika Bokori-Brown: Innovator in Vaccine Development

Introduction

Monika Bokori-Brown is a notable inventor based in The Queen's Drive, GB. She has made significant contributions to the field of medical science, particularly in the development of vaccines. Her innovative work focuses on addressing demyelinating conditions through her patented invention.

Latest Patents

Monika holds a patent for "Epsilon toxin from Clostridium perfringens as a vaccine." This invention relates to methods and compositions for detecting, diagnosing, preventing, treating, or ameliorating the symptoms of various demyelinating conditions. These conditions include enterotoxemia, multiple sclerosis, neuromyelitis optica spectrum disorder, and acute disseminated encephalomyelitis, among others. The methods involve administering a composition that interferes with epsilon toxin produced by specific bacterial strains, thereby inhibiting or suppressing receptor signaling activities. This innovative approach has the potential to significantly impact the treatment of these debilitating diseases.

Career Highlights

Monika Bokori-Brown has achieved recognition for her groundbreaking work in vaccine development. Her patent demonstrates her commitment to advancing medical science and improving patient outcomes. She is associated with One Health Ventures Ltd, where she continues to contribute to innovative research and development in the field.

Collaborations

Monika collaborates with Helen Morcrette, who is also a prominent figure in the field. Their partnership exemplifies the importance of teamwork in driving innovation and achieving breakthroughs in medical research.

Conclusion

Monika Bokori-Brown's contributions to vaccine development highlight her role as a leading inventor in the medical field. Her patented invention has the potential to transform the treatment of demyelinating conditions, showcasing the impact of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…